Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1957 1
1958 1
1960 1
1961 1
1963 1
1965 1
1967 1
1968 1
1970 2
1974 3
1976 1
1977 1
1982 1
1987 1
1991 1
2001 1
2003 1
2004 1
2005 5
2006 2
2007 3
2008 2
2009 1
2010 1
2011 2
2012 2
2013 3
2014 1
2015 1
2016 1
2017 1
2018 1
2020 2
2022 1
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Serial Monitoring of Otoacoustic Emissions in Clinical Trials.
Konrad-Martin D, Poling GL, Dreisbach LE, Reavis KM, McMillan GP, Lapsley Miller JA, Marshall L. Konrad-Martin D, et al. Among authors: dreisbach le. Otol Neurotol. 2016 Sep;37(8):e286-94. doi: 10.1097/MAO.0000000000001134. Otol Neurotol. 2016. PMID: 27518137 Review.
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.
Fernandez K, Hoetink A, Konrad-Martin D, Berndtson D, Clark K, Dreisbach L, Geller JI, Goffi-Gomez MV, Grosnik A, Jamis C, Knight K, Lee DS, Lee J, Liberman PHP, Milnes T, Meijer AJM, Ortiz CE, Rooker J, Sanchez VA, van den Heuvel-Eibrink MM, Brewer CC, Poling GL. Fernandez K, et al. Among authors: dreisbach l. Ear Hear. 2024 Sep 12. doi: 10.1097/AUD.0000000000001592. Online ahead of print. Ear Hear. 2024. PMID: 39261989
Repeatability of high-frequency thresholds.
Frank T, Dreisbach LE. Frank T, et al. Among authors: dreisbach le. Ear Hear. 1991 Aug;12(4):294-5. doi: 10.1097/00003446-199108000-00009. Ear Hear. 1991. PMID: 1783231
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Algazi AP, Othus M, Daud AI, Lo RS, Mehnert JM, Truong TG, Conry R, Kendra K, Doolittle GC, Clark JI, Messino MJ, Moore DF Jr, Lao C, Faller BA, Govindarajan R, Harker-Murray A, Dreisbach L, Moon J, Grossmann KF, Ribas A. Algazi AP, et al. Among authors: dreisbach l. Nat Med. 2020 Oct;26(10):1564-1568. doi: 10.1038/s41591-020-1060-8. Epub 2020 Oct 5. Nat Med. 2020. PMID: 33020646 Free PMC article. Clinical Trial.
Infrared studies of tissue lipides.
SCHWARZ HP, DREISBACH L, CHILDS R, MASTRANGELO SV. SCHWARZ HP, et al. Among authors: dreisbach l. Ann N Y Acad Sci. 1957 Sep 7;69(1):116-30. doi: 10.1111/j.1749-6632.1957.tb49653.x. Ann N Y Acad Sci. 1957. PMID: 13478995 No abstract available.
51 results